section name header

Footnotes

a Tested in both glass and PVC containers.

b Tested in PVC containers.

c Tested in glass containers.

d Tested with mannitol 1.875% and potassium chloride 20 mEq/L present.

e Tested with cyclophosphamide 2 g/L.

f Tested with floxuridine 700 mg/L.

g Tested with ifosfamide 2 g/L.

h Tested with cisplatin 200 mg/L.

i Tested with daunorubicin HCl (RP) 33 mg/L.

j Tested with daunorubicin HCl (BEL) 15.7 mg/L.

k Tested with cytarabine (UP) 267 mg/L.

l Tested with cytarabine (UP) 157 mg/L.

m Tested with vincristine sulfate (LI) 1.6 mg/L.

n Tested with vincristine sulfate (LI) 1 mg/L.

o Tested with vincristine sulfate (LI) 1.4 mg/L.

p Tested with vincristine sulfate (LI) 2 mg/L.

q Tested with vincristine sulfate (LI) 2.8 mg/L.

r Tested with vincristine sulfate (LI) 4 mg/L.

s Tested with doxorubicin HCl (PHU) 40 mg/L.

t Tested with doxorubicin HCl (PHU) 25 mg/L.

u Tested with doxorubicin HCl (PHU) 35 mg/L.

v Tested with doxorubicin HCl (PHU) 50 mg/L.

w Tested with doxorubicin HCl (PHU) 70 mg/L.

x Tested with doxorubicin HCl (PHU) 100 mg/L.